Antaros Medical contributes to the renal imaging initiative PARENCHIMA
January 29th, 2021
PARENCHIMA is a renal imaging initiative aiming to fill the gap of non-invasive and sensitive biomarkers for Chronic Kidney Disease (CKD), a disease affecting >10% of the world’s population. Magnetic Resonance Imaging (MRI) biomarkers show a strong potential to help fill this gap and support the development of effective treatments for CKD.
Back to all news